Rhythm Pharmaceuticals (RYTM) EBITDA (2016 - 2021)
Rhythm Pharmaceuticals' EBITDA was -$43.93 million in Q3 2021, compared with -$34.11 million a year earlier.
Powered by 
Analysis
Rhythm Pharmaceuticals (RYTM) EBITDA (2016 - 2021) Analysis & Trends
On a trailing twelve-month basis, Rhythm Pharmaceuticals' EBITDA was -$153.13 million through Sep 30, 2021; for FY2020, it was -$135.89 million.
- In earlier years, EBITDA was -$145.17 million in FY2019, -$77.98 million in FY2018, -$32.19 million in FY2017 and -$25.76 million in FY2016.
- The Q3 2021 figure marks the lowest quarterly EBITDA since Q2 2019.
- Per Business Quant data, RYTM's EBITDA in the three quarters before Q3 2021 was -$40.12 million (Q2 2021), -$34.2 million (Q1 2021) and -$34.9 million (Q4 2020).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Rhythm Pharmaceuticals | 6.78 Bn | 5.65 Bn | 62.32 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | -43.93 Mn |
| Jun 30, 2021 | -40.12 Mn |
| Mar 31, 2021 | -34.20 Mn |
| Dec 31, 2020 | -34.90 Mn |
| Sep 30, 2020 | -34.11 Mn |
| Jun 30, 2020 | -31.75 Mn |
| Mar 31, 2020 | -35.13 Mn |
| Dec 31, 2019 | -34.03 Mn |
| Sep 30, 2019 | -36.92 Mn |
| Jun 30, 2019 | -43.94 Mn |
| Mar 31, 2019 | -30.28 Mn |
| Dec 31, 2018 | -26.94 Mn |
| Sep 30, 2018 | -19.14 Mn |
| Jun 30, 2018 | -14.96 Mn |
| Mar 31, 2018 | -16.94 Mn |
| Dec 31, 2017 | -10.92 Mn |
| Sep 30, 2017 | -8.23 Mn |
| Jun 30, 2017 | -6.70 Mn |
| Mar 31, 2017 | -6.34 Mn |
| Dec 31, 2016 | -8.32 Mn |
API Access
Rhythm Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=RYTM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "RYTM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=RYTM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();